Mechanisms that regulate inflammation and repair after acute lung injury are incompletely understood. The extracellular matrix glycosaminoglycan hyaluronan is produced after tissue injury and impaired clearance results in unremitting inflammation. Here we report that hyaluronan degradation products require MyD88 and both Toll-like receptor (TLR)4 and TLR2 in vitro and in vivo to initiate inflammatory responses in acute lung injury. Hyaluronan fragments isolated from serum of individuals with acute lung injury stimulated macrophage chemokine production in a TLR4- and TLR2-dependent manner. Myd88(-/-) and Tlr4(-/-)Tlr2(-/-) mice showed impaired transepithelial migration of inflammatory cells but decreased survival and enhanced epithelial cell apoptosis after lung injury. Lung epithelial cell-specific overexpression of high-molecular-mass hyaluronan was protective against acute lung injury. Furthermore, epithelial cell-surface hyaluronan was protective against apoptosis, in part, through TLR-dependent basal activation of NF-kappaB. Hyaluronan-TLR2 and hyaluronan-TLR4 interactions provide signals that initiate inflammatory responses, maintain epithelial cell integrity and promote recovery from acute lung injury.
The angiogenic growth factor angiopoietin 2 (Ang2) destabilizes blood vessels, enhances vascular leak and induces vascular regression and endothelial cell apoptosis. We considered that Ang2 might be important in hyperoxic acute lung injury (ALI). Here we have characterized the responses in lungs induced by hyperoxia in wild-type and Ang2-/- mice or those given either recombinant Ang2 or short interfering RNA (siRNA) targeted to Ang2. During hyperoxia Ang2 expression is induced in lung epithelial cells, while hyperoxia-induced oxidant injury, cell death, inflammation, permeability alterations and mortality are ameliorated in Ang2-/- and siRNA-treated mice. Hyperoxia induces and activates the extrinsic and mitochondrial cell death pathways and activates initiator and effector caspases through Ang2-dependent pathways in vivo. Ang2 increases inflammation and cell death during hyperoxia in vivo and stimulates epithelial necrosis in hyperoxia in vitro. Ang2 in plasma and alveolar edema fluid is increased in adults with ALI and pulmonary edema. Tracheal Ang2 is also increased in neonates that develop bronchopulmonary dysplasia. Ang2 is thus a mediator of epithelial necrosis with an important role in hyperoxic ALI and pulmonary edema.
Thyroid hormone (TH) is critical for the maintenance of cellular
homeostasis during stress responses, but its role in lung fibrosis is unknown.
Here, we found that the activity and expression of iodothyronine deiodinase 2
(DIO2), an enzyme that activates TH, was higher in lungs of patients with
idiopathic pulmonary fibrosis compared to control individuals and correlated
with disease severity. We also found that Dio2 knockout mice
exhibited enhanced bleomycin-induced lung fibrosis. Aerosolized TH delivery
increased survival and resolved fibrosis in two models of pulmonary fibrosis in
mice (intratracheal bleomycin and inducible TGF-β1). Sobetirome, a TH
mimetic, also blunted bleomycin-induced lung fibrosis. Given after
bleomycin-induced injury, TH promoted mitochondrial biogenesis, improved
mitochondrial bioenergetics and attenuated mitochondria-regulated apoptosis in
alveolar epithelial cells both in vivo and in
vitro. TH did not blunt fibrosis in Ppargc1a or
Pink1 knockout mice suggesting dependence on these
pathways. We conclude that the TH anti-fibrotic properties are associated with
protection of alveolar epithelial cells and restoration of mitochondrial
function and thus may represent an effective therapy for pulmonary fibrosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.